Scientists find unexpected anti-cancer activity in range of non-oncology drugs — study
As the second leading cause of mortality globally, the lucrative field of cancer treatment has elicited a frenzy of drug development and billions in venture funding. But a new study suggests that cancer-killing compounds may be lurking in the existing arsenal of non-oncology medicines.
By analyzing thousands of FDA-approved drugs and compounds that have been proven safe in clinical trials, scientists at the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute found nearly 50 compounds — including drugs for diabetes, inflammation, alcoholism and even a treatment for arthritis in dogs — with previously undetected anti-cancer activity.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.